Proteomic analyses of brain tumor cell lines amidst the unfolded protein response
Metrics: PDF 1830 views | HTML 2178 views | ?
Jasmina S. Redzic1, Joe D. Gomez1, Justin E. Hellwinkel2, Thomas J. Anchordoquy1, Michael W. Graner2
1Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Denver Anschutz Medical Campus, Aurora, CO, USA
2Department of Neurosurgery, University of Colorado Denver Anschutz Medical Campus, Aurora, CO, USA
Jasmina S. Redzic, email: [email protected]
Keywords: brain tumor, glioma, proteomics, unfolded protein response, signaling
Received: February 28, 2016 Accepted: May 23, 2016 Published: June 14, 2016
Brain tumors such as high grade gliomas are among the deadliest forms of human cancers. The tumor environment is subject to a number of cellular stressors such as hypoxia and glucose deprivation. The persistence of the stressors activates the unfolded proteins response (UPR) and results in global alterations in transcriptional and translational activity of the cell. Although the UPR is known to effect tumorigenesis in some epithelial cancers, relatively little is known about the role of the UPR in brain tumors. Here, we evaluated the changes at the molecular level under homeostatic and stress conditions in two glioma cell lines of differing tumor grade. Using mass spectrometry analysis, we identified proteins unique to each condition (unstressed/stressed) and within each cell line (U87MG and UPN933). Comparing the two, we find differences between both the conditions and cell lines indicating a unique profile for each. Finally, we used our proteomic data to identify the predominant pathways within these cells under unstressed and stressed conditions. Numerous predominant pathways are the same in both cell lines, but there are differences in biological and molecular classifications of the identified proteins, including signaling mechanisms, following UPR induction; we see that relatively minimal proteomic alterations can lead to signaling changes that ultimately promote cell survival.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.